Article Figures & Data
Figures
- Abstract 482 Figure 1
Covariate-adjusted means of HR in adults by birth weight quartiles
- Abstract 499 Figure 1
- Abstract 562 Figure 1
- Abstract 562 Figure 2
- Abstract 563 Figure 1
Urine values of Albumin, β2MG, Cys C, EGF, NGAL, OPN, and UMOD in infants with AKI (gray circles) and infants without AKI (black circles) on day-1 and day 0.
Tables
- Abstract 513 Table 1
HP (n=12) HC (n=12) Parameters Baseline 6 months p-value Baseline 6 months P-value p* HP vs HC 6 months Age (yr) 43.1±1.3 41.1±1.8 Weight (lbs) 248.8±12.2 229.4±11.3 0.005 236.6±6.8 211±8.3 0.008 0.07 Blood Pressure 130/80±3/2 116/72±3/3 0.006 126/80±4/2 113/73±4/2 0.005 0.6 RMR 1571±19 1862±18 0.005 1569±17 1598±15 0.6 0.001 Irisin ( ng/ml) 9.41±0.7 10.42±0.4 0.03 8.86±0.8 8.99±0.8 0.5 0.02 FGF-21 (pg/ml) 166.39±41.36 129.47±24 0.04 114.25±30.48 166.39±30 0.05 0.06 UCP-1 (ng/ml) 0.30±0.06 0.33±0.07 0.05 0.82±0.35 0.62±0.26 0.03 0.04 p is significance of change from Baseline to 6 mo; p* is significance between HP vs HC at 6 mo. - Abstract 530 Table 1
Sensitivity and Specifity of PCR vs FISH for ALK
First Author Year N FISH+, PCR+ FISH+, PCR- FISH-, PCR+ FISH-, PCR- SNS SPC Lantuejoul S 2015 504 75 50 1 378 0.60 0.99 Soda M 2012 111 15 1 0 95 0.94 1.00 Wang J 2014 200 44 2 20 134 0.96 0.87 Wu Y 2013 305 7 5 2 291 0.58 0.99 Li Y 2013 161 38 6 0 117 0.86 1.00 Ying J 2013 196 62 1 7 126 0.98 0.95 Wallander ML 2012 46 7 5 4 30 0.64 0.88 SUM – 1523 248 70 34 1171 0.78 0.97 - Abstract 532 Table 1
Family History of Malignancies
Prostate Breast Pancreas Ovarian Other Malignancies Total VUS Group 16 (37%) 12 (28%) 3 (7%) 1 (2%) 11 (26%) 43 Negative Group 33 (51%) 15 (23%) 4 (6%) 5 (8%) 8 (12%) 65 Table 1. Comparison of incidence of prostate, breast, pancreatic, ovarian, and other malignancies in the VUS group and the negative group
- Abstract 548 Table 1
Published Cases Emory Cohort Total IDU n(%) 30 (55.6%) 3 (60%) 33 (56%) Native valve n(%) 36 (66.7%) 5 (100%) 41 (69%) Left heart disease n(%) 29 (53.7%) 3 (60%) 32 (54%) Embolic phenomena n(%) 30 (55.6%) 3 (60%) 33 (56%) Vegetation size (mm)
(mean/standard deviation)15.5 (2.1) 14.2 (2.9) 15.2 (2.3) Survival to discharge n(%) 23 (42.6%) 3 (60%) 26 (44%) - Abstract 554 Table 1
Patients PPH Acuity PGY N Avg Max Min SD Avg Max Min SD Avg Max Min SD 1 36 157 232 87 34 0.98 1.57 0.66 0.18 3.6 3.97 2.98 0.18 2 41 183 307 110 43 1.14 1.66 0.66 0.19 3.56 3.95 3.30 0.19 3 18 187 260 126 36 1.21 1.84 0.78 0.28 3.59 3.99 3.36 0.28 - Abstract 560 Table 1
Gravity (NG only) 1-hour feeding pump (NG+60" extension tube) Silicone Polyurethane Silicone Polyurethane Fat −5.9±3.5 −7.4±0.7 −17.7±11.0 −22.3±7.1*, ^ Energy −2.7±1.5 −4.2±0.6 −7.8±4.6 −12.1±3.6**,^^ *p=0.032 compared to polyurethane NG (gravity)
^p=0.02 compared to silicone NG (gravity)
**p=0.017 compared to polyurethane NG (gravity)
^^p=0.006 compared to silicone NG (gravity)
- Abstract 569 Table 1
Health Care Utilization in Late Preterm versus Term Infants*
Office Emergency Room Hospital Other Term 6.8 (±4.7) 1.0 (±1.9) 1.2 (±5.0) 2.6 (±4.5) Late preterm 6.9 (±4.8) 1.2 (±2.1) 3.7 (±10.1) 3.4 (±6.6) Poisson regression †
−IRR††0.08 3.3 0.38 0.73 - Abstract 575 Table 1
Referral in patients with GFR<20 in different study phases. Results presented as N(%)
Phase 1 Phase 2 Phase 3 GFR 15-20 GFR<15 GFR 15-20 GFR<15 GFR 15-20 GFR<15 N 79 36 30 22 18 29 Transplant Referral 9 (11%) 18 (50%) 11 (37%) 15 (67%) 8 (44%) 19 (66%) Vascular Access Referral 26 (72%) 16 (73%) 21 (72%)
- Article
- Cardiovascular Club II, 10:30 AM
- Adolescent Medicine and Pediatrics, Concurrent Session, 1:00 PM
- Allergy, Immunology, and Rheumatology II
- Endocrinology and Metabolism
- Health Care Research and Quality Improvement
- Hematology and Oncology II
- Infectious Diseases II
- Medical Education, Medical Ethics, and Advocacy
- Perinatal Medicine II
- Renal, Electrolyte and Hypertension II
- Figures & Data
- eLetters
- Info & Metrics